The CRISPR/Cas system inhibited the pro‐oncogenic effects of alternatively spliced fibronectin extra domain A via editing the genome in salivary adenoid cystic carcinoma cells

Publisher: John Wiley & Sons Inc

E-ISSN: 1601-0825|21|5|608-618

ISSN: 1354-523x

Source: ORAL DISEASES, Vol.21, Iss.5, 2015-07, pp. : 608-618

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract